Table of Contents
1 Study Coverage
1.1 Budesonide Aerosol Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Budesonide Aerosol Market Size Growth Rate by Type
1.4.2 50ug/200 Spray
1.4.3 100ug/200 Spray
1.4.4 200ug/100 Spray
1.4.5 Other
1.5 Market by Application
1.5.1 Global Budesonide Aerosol Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Budesonide Aerosol Market Size
2.1.1 Global Budesonide Aerosol Revenue 2014-2025
2.1.2 Global Budesonide Aerosol Sales 2014-2025
2.2 Budesonide Aerosol Growth Rate by Regions
2.2.1 Global Budesonide Aerosol Sales by Regions
2.2.2 Global Budesonide Aerosol Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Budesonide Aerosol Sales by Manufacturers
3.1.1 Budesonide Aerosol Sales by Manufacturers
3.1.2 Budesonide Aerosol Sales Market Share by Manufacturers
3.2 Budesonide Aerosol Revenue by Manufacturers
3.2.1 Budesonide Aerosol Revenue by Manufacturers (2014-2019)
3.2.2 Budesonide Aerosol Revenue Share by Manufacturers (2014-2019)
3.3 Budesonide Aerosol Price by Manufacturers
3.4 Budesonide Aerosol Manufacturing Base Distribution, Product Types
3.4.1 Budesonide Aerosol Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Budesonide Aerosol Product Type
3.4.3 Date of International Manufacturers Enter into Budesonide Aerosol Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Budesonide Aerosol Sales by Type
4.2 Global Budesonide Aerosol Revenue by Type
4.3 Budesonide Aerosol Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Budesonide Aerosol Breakdown Data by Application
6 North America
6.1 North America Budesonide Aerosol by Country
6.1.1 North America Budesonide Aerosol Sales by Country
6.1.2 North America Budesonide Aerosol Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Budesonide Aerosol by Type
6.3 North America Budesonide Aerosol by Application
7 Europe
7.1 Europe Budesonide Aerosol by Country
7.1.1 Europe Budesonide Aerosol Sales by Country
7.1.2 Europe Budesonide Aerosol Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Budesonide Aerosol by Type
7.3 Europe Budesonide Aerosol by Application
8 Asia Pacific
8.1 Asia Pacific Budesonide Aerosol by Region
8.1.1 Asia Pacific Budesonide Aerosol Sales by Region
8.1.2 Asia Pacific Budesonide Aerosol Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Budesonide Aerosol by Type
8.3 Asia Pacific Budesonide Aerosol by Application
9 Central & South America
9.1 Central & South America Budesonide Aerosol by Country
9.1.1 Central & South America Budesonide Aerosol Sales by Country
9.1.2 Central & South America Budesonide Aerosol Revenue by Country
9.1.3 Brazil
9.2 Central & South America Budesonide Aerosol by Type
9.3 Central & South America Budesonide Aerosol by Application
10 Middle East and Africa
10.1 Middle East and Africa Budesonide Aerosol by Country
10.1.1 Middle East and Africa Budesonide Aerosol Sales by Country
10.1.2 Middle East and Africa Budesonide Aerosol Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Budesonide Aerosol by Type
10.3 Middle East and Africa Budesonide Aerosol by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Budesonide Aerosol Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Budesonide Aerosol Products Offered
11.2.5 Pfizer Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Business Overview
11.3.3 Teva Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Budesonide Aerosol Products Offered
11.3.5 Teva Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Company Business Overview
11.4.3 Cipla Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cipla Budesonide Aerosol Products Offered
11.4.5 Cipla Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Company Business Overview
11.5.3 Novartis Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Novartis Budesonide Aerosol Products Offered
11.5.5 Novartis Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Company Business Overview
11.6.3 Mylan Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Mylan Budesonide Aerosol Products Offered
11.6.5 Mylan Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Company Business Overview
11.7.3 Abbott Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abbott Budesonide Aerosol Products Offered
11.7.5 Abbott Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Company Business Overview
11.8.3 Takeda Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Takeda Budesonide Aerosol Products Offered
11.8.5 Takeda Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Business Overview
11.9.3 Boehringer Ingelheim Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Boehringer Ingelheim Budesonide Aerosol Products Offered
11.9.5 Boehringer Ingelheim Recent Development
11.10 Allgen Pharmaceuticals
11.10.1 Allgen Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Allgen Pharmaceuticals Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Allgen Pharmaceuticals Budesonide Aerosol Products Offered
11.10.5 Allgen Pharmaceuticals Recent Development
11.11 Squibb
11.12 Sandoz
11.13 Shimadzu Corp
11.14 Manus Aktteva Biopharma LLP
11.15 Skyepharma
11.16 Shanghai Sine Pharmaceutical
11.17 Lunan Better Pharmaceutical
11.18 Wellcome Australia Ltd
11.19 Synmosa Biopharma Corporation
11.20 Chiesi Farmaceutici S.p.A
12 Future Forecast
12.1 Budesonide Aerosol Market Forecast by Regions
12.1.1 Global Budesonide Aerosol Sales Forecast by Regions 2019-2025
12.1.2 Global Budesonide Aerosol Revenue Forecast by Regions 2019-2025
12.2 Budesonide Aerosol Market Forecast by Type
12.2.1 Global Budesonide Aerosol Sales Forecast by Type 2019-2025
12.2.2 Global Budesonide Aerosol Revenue Forecast by Type 2019-2025
12.3 Budesonide Aerosol Market Forecast by Application
12.4 North America Budesonide Aerosol Forecast
12.5 Europe Budesonide Aerosol Forecast
12.6 Asia Pacific Budesonide Aerosol Forecast
12.7 Central & South America Budesonide Aerosol Forecast
12.8 Middle East and Africa Budesonide Aerosol Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Budesonide Aerosol Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
AstraZeneca、Pfizer、Teva、Cipla、Novartis、Mylan、Abbott、Takeda、Boehringer Ingelheim、Allgen Pharmaceuticals、Squibb、Sandoz、Shimadzu Corp、Manus Aktteva Biopharma LLP、Skyepharma、Shanghai Sine Pharmaceutical、Lunan Better Pharmaceutical、Wellcome Australia Ltd、Synmosa Biopharma Corporation、Chiesi Farmaceutici S.p.A